Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Checklist for Prescribers - Teragezza

Please use this checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations. Cyproterone acetate and ethinylestradiol tablet are used for the treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age.

For Healthcare Professionals

Important Information for Women - Teragezza

The review recommended that all women should understand: the small risk of blood clots with combined hormonal contraceptives; what other conditions increase the risk of a blood clot; the signs and symptoms of a blood clot; and when you need to tell a healthcare professional that you are using a combined hormonal contraceptive. Although the risk is small, blood clots can be serious. This information will help you minimise your risk.

Patient Alert Card - Teragezza

Risk of blood clots with combined hormonal contraceptives. All combined contraceptives increase the rare but important risk of having a blood clot. It is important to recognise the signs and symptoms to look out for and what action to take.

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.